Sort
64,565 grants matching “drug discovery”
APOBEC3 STRUCTURAL STUDIES
$529,626Reuben S Harris · University Of Minnesota · R01 · FY2017 · GM
Developmental Research Project Program
$529,544Barbara E Goodman · University Of South Dakota · P20 · FY2017 · GM
Mass Spectrometric Studies of Thiotemplate Biosynthesis
$529,491Neil L Kelleher · Northwestern University At Chicago · R01 · FY2010 · GM
Magnetic Resonance-guided Focused Ultrasound Ablation of the Anterior Thalamus as a Novel Treatment Paradigm for Anxiety
$529,485Kinh Luan Phan · Ohio State University · U01 · FY2024 · MH
Screening for inhibitors of NSD3 as a treatment for lung cancer
$529,475Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Multi-omics approaches to lower the barriers to sustainable production of plant natural products with relevance to human health
$529,426Carol Robin Buell · University Of Georgia · R01 · FY2024 · AT
Development of Novel Informative Preclinical Animal Models - CAPR Infrastructure
$529,416Shyam Sharan · Division Of Basic Sciences - Nci · ZIG · FY2018 · CA
Aging in 1000 healthy young adults: the Dunedin Study
$529,407Terrie Edith Moffitt · Duke University · R01 · FY2016 · AG
Aging in 1000 healthy young adults: the Dunedin Study
$529,407Terrie Edith Moffitt · Duke University · R01 · FY2017 · AG
Aging in 1000 healthy young adults: the Dunedin Study
$529,407Terrie Edith Moffitt · Duke University · R01 · FY2019 · AG
A synergy-based therapy against C. difficile
$529,393Kim Lewis · Northeastern University · R01 · FY2011 · AI
CORE BIOLOGY AND SYNTHESIS FACILITIES
$529,371Mukund P. Sibi · North Dakota State University · P20 · FY2011 · RR
Peripheral and Central Pathways of α3 Glycine Receptors as Non-Opioid Molecular Targets to Treat Pain
$529,362Yan Xu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · NS
Use of a Nano-Enabled Platform for Pancreatic Cancer Immunotherapy
$529,313Andre Elias Nel · University Of California Los Angeles · R01 · FY2022 · CA
Gene Control and Cell Growth Regulation by Interferon
$529,289Rockefeller University · R01 · FY2002 · AI
Rapid Development of a Lead Aromatic Aldehyde Derivative with both Oxygen Dependent and Novel, Oxygen Independent Anti-Sickling Effects: Building on a Paradigm Shift in Sickle Cell Disease Therapy
$529,259David Richard Light · Illexcor Therapeutics, Llc · R44 · FY2025 · HL
Bridging Pediatric and Adult Biomarkers of Graft-Versus-Host-Disease
$529,239Sophie Paczesny · Indiana University Indianapolis · R01 · FY2013 · HD
Developing Metallo-Beta-Lactamase Inhibitors
$529,229Walter L Fast · University Of Texas At Austin · R01 · FY2017 · GM
New Modalities for the Treatment of Pain and Drug Abuse
$529,210Frank Porreca · University Of Arizona · P01 · FY2020 · DA
New Modalities for the Treatment of Pain and Drug Abuse
$529,210Frank Porreca · University Of Arizona · P01 · FY2021 · DA
DEVELOPMENTAL FUNDS (Core-002)
$529,186Jennifer A Pietenpol · Vanderbilt University · P30 · FY2015 · CA
DEVELOPMENTAL FUNDS (Core-002)
$529,186Jennifer A Pietenpol · Vanderbilt University Medical Center · P30 · FY2016 · CA
Discovering Modular Catalysts for Selective Synthesis with Computation
$529,170Robert S Paton · Colorado State University · · FY2024 · MPS
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease
$529,129Russell Dahl · Neurodon Llc · R44 · FY2023 · AG
NOTCH3 Signaling in Pulmonary Hypertension
$529,102Patricia A Thistlethwaite · University Of California, San Diego · R01 · FY2018 · HL